(1) Beck, T. C.; Reichel, C. M.; Helke, K. L.; Bhadsavle, S. S.; Dix, T. A. Non-Addictive Orally-Active Kappa Opioid Agonists for the Treatment of Peripheral Pain in Rats. Eur. J. Pharmacol. 2019, 856, 172396. https://doi.org/10.1016/j.ejphar.2019.05.025.

(2)        Hughes, Jr., F. M. Development of a Peptide-Derived Orally-Active Kappa-Opioid Receptor Agonist Targeting Peripheral Pain. Open Med. Chem. J. 2013, 7 (1), 16–22. https://doi.org/10.2174/1874104501307010016.

(3)        Zhao, X.; Jones, A.; Olson, K. R.; Peng, K.; Wehrman, T.; Park, A.; Mallari, R.; Nebalasca, D.; Young, S. W.; Xiao, S.-H. A Homogeneous Enzyme Fragment Complementation-Based β-Arrestin Translocation Assay for High-Throughput Screening of G-Protein-Coupled Receptors. J. Biomol. Screen. 2008, 13 (8), 737–747. https://doi.org/10.1177/1087057108321531.